In Conversation

“ Our priority is to strengthen Asia’s role in both the development and the delivery of innovative therapies ”
“ Despite recent advances in cancer immunotherapy, approximately 80 percent of patients still do not respond, or become resistant, to currently available immuno-oncology treatments ”
“ International pharmaceutical companies [should] not only look at Japan as a single country, but also as the gateway to Asia ”
“ Step-by-step, we are increasing the presence and engagement of Takeda Oncology Japan, leveraging the strength of our other therapeutic area business units, and stakeholders are increasingly… ”
“ We are confident that 2020 and 2021 will be very relevant years for regenerative medicine in Japan ”
“ The greatest strength of Molcure’s system is the ability to discover drugs that could never be found by using conventional methods ”
“ What is most important to stress is that there are many different applications for our technology, particularly in the field of regenerative medicine.  ”
“ "Bio is something that Japan has not always been on the frontline of" ”
“ FIRM acts as a form of translational bridge between academia and the market, bringing the results of academia to the patient ”
“ The most important item, these past five years, has been winning the trust of the public, the industry and academia alike ”
“ We aim to stimulate the biomedical industry and our main mission is to fast-track medical R&D and improve three different types of lives: lifespan, daily life,… ”
“ "Despite Japan’s efforts to improve translational research and bring academia closer to the industry, bioIPSeeds actually perfectly embodies the kind of pioneering tool that could benefit… ”
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here